Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2025 ,inter alia, to consider and approve 1) To Consider and approve the Audited Financial Results (Standalone and consolidated) of the Company for the fourth quarter and financial year ended March 31, 2025.2) Any Other Business matter, with the permission of the Chair.
Transgene Biotek Limited. Press Release Apr 26 2025
Filed with BSE · · 1 page · English
Release
Transgene Biotek Limited on 6ix
Story so far
Earlier from Transgene Biotek
- Compliance-57 (5): intimation after the end of quarter
- We Are Enclosing Hereto The Compliance Certificate As Per Clause 40(9) In The Prescribed Format For The Quarter Ended 31St March, 2025
- Transgene Biotek Limited. Press Release Apr 24 2025
- Transgene Biotek Limited. Press Release Apr 19 2025
- Statement Of Deviation & Variation
Later from Transgene Biotek
- Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31, 2025
- Transgene Biotek Limited. Press Release May 07 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Transgene Biotek Limited. Press Release May 12 2025
- Integrated Filing (Financial)
Follow Transgene Biotek into a list and get an email when it puts out news.
Follow Transgene Biotek